Correlation Between Genmab AS and Nnit AS
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Nnit AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Nnit AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Nnit AS, you can compare the effects of market volatilities on Genmab AS and Nnit AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Nnit AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Nnit AS.
Diversification Opportunities for Genmab AS and Nnit AS
Weak diversification
The 3 months correlation between Genmab and Nnit is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Nnit AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nnit AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Nnit AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nnit AS has no effect on the direction of Genmab AS i.e., Genmab AS and Nnit AS go up and down completely randomly.
Pair Corralation between Genmab AS and Nnit AS
Assuming the 90 days trading horizon Genmab AS is expected to under-perform the Nnit AS. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 1.99 times less risky than Nnit AS. The stock trades about -0.19 of its potential returns per unit of risk. The Nnit AS is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 10,800 in Nnit AS on September 5, 2024 and sell it today you would lose (1,570) from holding Nnit AS or give up 14.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Genmab AS vs. Nnit AS
Performance |
Timeline |
Genmab AS |
Nnit AS |
Genmab AS and Nnit AS Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genmab AS and Nnit AS
The main advantage of trading using opposite Genmab AS and Nnit AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Nnit AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nnit AS will offset losses from the drop in Nnit AS's long position.Genmab AS vs. Ambu AS | Genmab AS vs. DSV Panalpina AS | Genmab AS vs. Bavarian Nordic | Genmab AS vs. GN Store Nord |
Nnit AS vs. Spar Nord Bank | Nnit AS vs. Skjern Bank AS | Nnit AS vs. Djurslands Bank | Nnit AS vs. Alefarm Brewing AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |